优先安排腮腺手术:呼吁实施MSRSGC分类
该研究基于荷兰全国病理数据库评估腮腺肿瘤细针穿刺细胞学(FNAC)至手术开始时间(TTI),并按MSRSGC分类分析,同时评估该分类在荷兰的应用情况。结果显示多数类别中位TTI较长且医院间差异显著,2018至2021年仅6.4%报告注明MSRSGC分类。作者呼吁改善术前风险分层与手术优先级并推广MSRSGC。
要点
- MSRSGC V和VI类中位TTI较短(31天和30天),提示优先手术。
- MSRSGC I至IVb类中位TTI为52至89天,多数类别等待时间较长。
- 荷兰MSRSGC分类实施率低,仅6.4%报告注明分类。
核心结论
- 多数MSRSGC类别中位TTI较长,且医院间TTI差异显著。
- 荷兰腮腺手术的术前风险分层与治疗优先排序应改善,MSRSGC可发挥作用。
- 截至2021年,MSRSGC分类在荷兰应用规模有限。
研究设计与样本
- 基于荷兰全国病理数据库(PALGA)收集腮腺FNAC与组织病理切除数据。
- 按MSRSGC类别和治疗中心类型计算TTI。
- 收集2018至2021年FNAC数据评估MSRSGC分类应用频率。
主要发现
- 中位TTI(天):MSRSGC I为86,II为75,III为65,IVa为89,IVb为52,V为31,VI为30。
- 非诊断、非肿瘤、AUS、SUMP和可疑恶性类别中,不同治疗中心类型间TTI存在显著差异。
- MSRSGC引入后前3年,病理医生在6.4%的所有报告中注明MSRSGC分类。
临床怎么用
- 可参考MSRSGC类别对腮腺手术进行术前风险分层和优先排序。
- 对MSRSGC V和VI类应优先安排手术,以缩短TTI。
- 应提高病理报告中MSRSGC分类的注明率以促进其临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is developed to aid diagnosis and management of salivary gland tumors. This study evaluates the time-to-treatment initiation (TTI) for parotid gland tumors in the Netherlands and relates these to the MSRSGC classification. Subsequently, the use of the MSRSGC in the Netherlands is evaluated. METHODS: Data regarding fine-needle aspiration cytology (FNAC) and histopathological resections of the parotid were gathered from the Dutch nationwide pathology data bank (PALGA). The TTI was calculated for each MSRSGC category and type of treating center. FNACs performed from 2018 to 2021 were gathered from PALGA to estimate how frequently the MSRSGC classification was applied. RESULTS: Median TTI in days were 86 for nondiagnostic (MSRSGC I), 75 for nonneoplastic (MSRSGC II), 65 for atypia of unknown significance (AUS) (MSRSGC III), 89 for benign (MSRSGC IVa), 52 for salivary gland neoplasm of unknown malignant potential (SUMP) (MSRSGC IVb), 31 for suspected malignant (MSRSGC V), and 30 for malignant (MSRSGC VI) categories. Significant variation in the TTI between the types of treating centers was found for the nondiagnostic, nonneoplastic, AUS, SUMP, and suspected malignant categories. In the first 3 years after the introduction of the MSRSGC, the pathologist stated the MSRSGC classification in 6.4% of all reports. CONCLUSIONS: The median TTI for most categories is long, and there is significant interhospital variation in TTI. Preoperative risk stratification and treatment prioritization in parotid gland surgery in the Netherlands should be improved. The MSRSGC could contribute to this. Until 2021, the MSRSGS classification was implemented on a limited scale in the Netherlands.
引用
- Reerds STH, Honings J, van Engen ACH, et al. Prioritizing parotid gland surgery: A call for the implementation of the MSRSGC classification. Cancer Cytopathol. 2023. PMID: 37519238. doi:10.1002/cncy.22747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。